Bisphosphonates as Antitumor Agents in Breast Cancer
January 6, 2012 | Hematology and Oncology
Author and Disclosure Information
SAN ANTONIO – Dr. Hope S. Rugo, associate editor of The Oncology Report, discusses the use of bisphosphonates as antitumor agents in early-stage breast cancer at the 2011 San Antonio Breast Cancer Symposium.